Cancers 2010, 2(2), 364-375; doi:10.3390/cancers2020364
Review

Cerebral Metastases from Malignant Melanoma: Current Treatment Strategies, Advances in Novel Therapeutics and Future Directions

email and * email
Received: 11 March 2010; in revised form: 25 March 2010 / Accepted: 1 April 2010 / Published: 6 April 2010
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Of all primary cancers in humans, melanoma has the highest propensity to metastasize to the brain. The prognosis of patients with this disease is extremely poor. Due to its radioresistance and poor response to existing chemotherapeutic regimes, no treatment options other than surgical extirpation, when feasible, have been shown to be effective. An understanding of the underlying tumor biology therefore remains the cornerstone of offering new hope in the treatment. In this review, we comment on the current treatment strategies for melanoma brain metastases and summarize some recent experimental findings from our laboratory with potential for the development of target specific antitumor therapies.
Keywords: cerebral metastasis; melanoma; surgery; radiotherapy; drug therapy; STAT3 transcription factor
PDF Full-text Download PDF Full-Text [241 KB, uploaded 6 April 2010 13:35 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Siu, T.L.; Huang, S. Cerebral Metastases from Malignant Melanoma: Current Treatment Strategies, Advances in Novel Therapeutics and Future Directions. Cancers 2010, 2, 364-375.

AMA Style

Siu TL, Huang S. Cerebral Metastases from Malignant Melanoma: Current Treatment Strategies, Advances in Novel Therapeutics and Future Directions. Cancers. 2010; 2(2):364-375.

Chicago/Turabian Style

Siu, Timothy L.; Huang, Suyun. 2010. "Cerebral Metastases from Malignant Melanoma: Current Treatment Strategies, Advances in Novel Therapeutics and Future Directions." Cancers 2, no. 2: 364-375.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert